Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BNTC | US
-0.72
-7.06%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
04/10/2024
9.48
9.90
10.26
8.49
Benitec Biopharma Inc. a development-stage biotechnology company focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301 an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. The company was incorporated in 1995 and is headquartered in Hayward California.
View LessPositive Momentum
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
Weakness based on declining price with high volume
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
126.5%1 month
88.7%3 months
70.0%6 months
103.1%-
-
1.97
-
-
0.27
10.46K
-
-22.40M
95.62M
95.62M
-
-
-
12.50
-91.68
3.96
0.79
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
4.69
Range1M
4.83
Range3M
5.84
Rel. volume
1.71
Price X volume
488.80K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Relmada Therapeutics Inc | RLMD | Drug Manufacturers-Specialty & Generic | 3.48 | 105.01M | 2.35% | n/a | 0.00% |
INC Research Holdings Inc | INCR | Drug Manufacturers-Specialty & Generic | 1.87 | 85.58M | 2.75% | n/a | 41.98% |
SCYNEXIS Inc | SCYX | Drug Manufacturers-Specialty & Generic | 1.44 | 54.51M | 0.70% | n/a | 25.73% |
Provectus Biopharmaceuticals Inc | PVCT | Drug Manufacturers-Specialty & Generic | 0.1014 | 42.58M | 4.54% | n/a | 0.00% |
DURECT Corporation | DRRX | Drug Manufacturers-Specialty & Generic | 1.24 | 38.49M | -7.46% | n/a | 318.92% |
India Globalization Capital Inc | IGC | Drug Manufacturers-Specialty & Generic | 0.3705 | 28.02M | -3.89% | n/a | 4.33% |
Lipocine Inc | LPCN | Drug Manufacturers-Specialty & Generic | 4.66 | 25.85M | 9.65% | n/a | 0.00% |
Flora Growth Corp. Common Stock | FLGC | Drug Manufacturers-Specialty & Generic | 1.56 | 20.85M | -8.77% | n/a | 76.81% |
MEI Pharma Inc | MEIP | Drug Manufacturers-Specialty & Generic | 2.81 | 18.72M | 2.18% | 1.09 | 0.00% |
Cumberland Pharmaceuticals Inc | CPIX | Drug Manufacturers-Specialty & Generic | 1.25 | 17.62M | 0.81% | n/a | 81.86% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 31.64 | 90.86M | -0.32% | 5.47 | 19.82% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 7.64 | 83.40M | -1.93% | n/a | 58.43% |
Culp Inc | CULP | Textile Manufacturing | 5.95 | 74.32M | -2.30% | n/a | 11.29% |
ILAG | ILAG | Building Products & Equipment | 1.0599 | 19.14M | -0.93% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.695 | 8.47M | -4.15% | n/a | 16.03% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.6199 | 5.90M | 6.82% | n/a | 19.98% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.33 | 5.20M | 0.03% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.3899 | 3.55M | -0.01% | n/a | 9.62% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.4859 | 2.44M | -9.19% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.01 | 913.02K | -1.96% | n/a | -37.05% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 0.27 | 17.21 | Cheaper |
Ent. to Revenue | 10,457.70 | 334.38 | Expensive |
PE Ratio | - | 26.92 | - |
Price to Book | 1.97 | 12.15 | Cheaper |
Dividend Yield | - | 2.77 | - |
Std. Deviation (3M) | 70.03 | 68.34 | Par |
Debt to Equity | - | -1.00 | - |
Debt to Assets | - | 0.48 | - |
Market Cap | 95.62M | 5.31B | Emerging |